HeathcareEMA adds transverse myelitis as possible adverse effect of...

EMA adds transverse myelitis as possible adverse effect of AstraZeneca and Janssen vaccines

-

- Advertisement -

Lima, January 14, 2022Updated on 01/14/2022 12:26 pm

The European Medicines Agency (EMA) today added transverse myelitis, a neurological condition, as a very rare possible adverse reaction to HIV vaccines. COVID-19 developed by AstraZeneca and Janssen, and stressed that this side effect occurs with an “unknown frequency.”

The safety committee (PRAC) has recommended a change to the product information for Vaxzevria (brand name of the AstraZeneca vaccine) and Janssen to include a warning for healthcare professionals and patients receiving one of these vaccines, so that are (MT) after vaccination.

- Advertisement -

In addition, this neurological disorder has been added to the package insert as “side effect of unknown frequency “, which also allows health workers to be alert to the signs and symptoms of this condition for early diagnosis and treatment.

The EMA explains that transverse myelitis is caused by and can cause weakness in the arms or legs, sensory symptoms (such as tingling, numbness, pain, or loss of pain sensation), or problems with bladder or bowel function. .

- Advertisement -

The PRAC has reviewed information on suspected cases of this disorder reported globally after vaccination (which does not necessarily mean that it is a vaccine in one or all cases), including European data, together with scientific literature for both vaccines. .

After this review, EMA experts have concluded that there is a “reasonable possibility” that there is a “causal relationship” between these two vaccines and transverse myelitis, but that of both vaccines remains positive when it comes to preventing COVID -19 severe and hospitalization for the disease caused by SARS-CoV-2.

On the other hand, the PRAC also recommended updating the AstraZeneca package insert to add more information on very rare cases of thrombosis with thrombocytopenia (TTS), as there were fewer reports of this adverse reaction after vaccination with the second dose.

Of the 1,809 cases of thrombocytopenia reported worldwide, 1,643 were after the first dose and 166 after the second.

The EMA currently advises against a second dose of AstraZeneca in people who have experienced thrombocytopenia after the first vaccination.

.

- Advertisement -
spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

The Cuban prosecutor’s office confirmed that there are more than 700 prosecuted for the July protests

The prosecution of Cuba numbered more than 700 those accused of participating in the protests last July, who are...

The US urges Russia in a letter to decide if it prefers diplomacy or confrontation

Secretary of State for U.S, Antony Blinken, remarked this Wednesday that now it corresponds to Russia decide whether...

El Comercio’s Qatar 2022 calculator: Will the team be able to qualify for the World Cup again?

The peruvian national team faces a decisive final stretch in these playoffs. to the team of Ricardo...

An Argentinean is shot dead in the tourist resort of Playa del Carmen, in Mexico

Two armed men murdered an Argentine who worked as manager of a popular club in Playa del Carmen, in...

Argentina National Team – Chile live: watch the match on TV, online and apps

Argentina – Chile They face each other from 8:00 p.m. in Calama on the 15th date of...

Must read

You might also likeRELATED
Recommended to you